Plasminogen Activator Inhibitor 1, Plasma

3 Day(s)

Reference Range

Plasminogen activator inhibitor-1 (PAI-1) is the principal inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA), the activators of plasminogen and hence fibrinolysis. Levels vary on a diurnal basis (higher in the morning) and are increased during pregnancy. HIGH levels of PAI-1 are observed in arterial thrombosis (myocardial infarction), inflammation and metabolic disorders (e.g. hypertriglyceridemia and hyperinsulinemia). Levels are also increased in a number of circumstances which are associated with venous thrombosis, including obesity, cancer and post-operative convalescence. See also Tissue Plasminogen Activator (tPA), Plasma

Special Requirements

Ready within 3

Copyright © biolab 2024, Developed by Tech Factory

Hit enter to search or ESC to close